Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 1.19B | 1.21B | 1.16B | 1.04B | 994M | 1.00B |
| Cost of revenue | 442M | 478M | 468M | 447M | 400M | 378M |
| Gross profit | 750M | 731M | 689M | 589M | 594M | 627M |
| Research and development | 145M | 158M | 148M | 145M | 135M | 136M |
| Selling, general and administrative | 350M | 331M | 328M | 310M | 306M | 333M |
| Operating expenses | 495M | 489M | 476M | 455M | 442M | 469M |
| Operating income | 255M | 243M | 213M | 134M | 152M | 158M |
| Pre-tax income | 270M | 352M | 241M | 154M | 177M | 188M |
| Income tax | 70M | 69M | 61M | 49M | 43M | 44M |
| Net income | 200M | 284M | 180M | 105M | 135M | 144M |
| Earnings per share | 0.52 | 0.73 | 0.46 | 0.27 | 0.34 | 0.36 |
| Earnings per share, diluted | 0.51 | 0.70 | 0.45 | 0.27 | 0.34 | 0.35 |
| Weighted average shares | 385M | 391M | 392M | 391M | 394M | 399M |
| Weighted average shares, diluted | 394M | 407M | 408M | 408M | 410M | 417M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.12B | 918M | 1.84B | 1.16B | 905M | 606M | 621M | 939M |
| Receivables | 1.09B | 1.22B | 1.11B |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 526M | — | — | 184M | — | — |
| Depreciation and amortisation | 67M | 64M | 63M | 60M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 1.35B |
| 1.16B |
| 1.01B |
| 1.00B |
| 945M |
| Inventory | 694M | 629M | 604M | 571M | 538M | 543M | 586M | 570M |
| Current assets | 4.33B | 4.03B | 5.22B | 5.03B | 4.55B | 4.30B | 4.26B | 4.85B |
| Goodwill | 24M | 24M | 24M | 24M | 23M | 23M | 24M | 23M |
| Total assets | 6.63B | 6.34B | 7.50B | 7.33B | 6.75B | 6.48B | 6.35B | 6.80B |
| Current liabilities | 2.22B | 2.14B | 3.34B | 3.31B | 3.04B | 2.93B | 1.73B | 1.72B |
| Total liabilities | 3.68B | 3.59B | 4.77B | 4.75B | 4.49B | 4.38B | 4.37B | 4.36B |
| Equity | 2.96B | 2.75B | 2.73B | 2.57B | 2.27B | 2.10B | 1.98B | 2.43B |
| Shares outstanding | 386M | 385M | 390M | 392M | 392M | 391M | 391M | 401M |
| Shares issued | 412M | 411M | 411M | 410M | 410M | 409M | 409M | 409M |
| Treasury shares | 26M | 26M | 21M | 18M | 18M | 18M | 18M | 8M |
| 55M |
| 52M |
| Share-based compensation | 43M | — | — | 34M | — | — |
| Capital expenditure | 77M | — | — | 87M | — | — |
| Investing cash flow | −299M | — | — | 100M | — | — |
| Financing cash flow | −25M | — | — | 13M | — | — |